An AI model for target IOP prediction performs as well as glaucoma specialists, offering a promising tool to enhance glaucoma management, especially for nonspecialists.
A recent study of cannabinol in in vitro and in vivo glaucoma models, demonstrated encouraging results that may address some of the previous challenges associated with cannabis use and may present a new potential therapeutic intervention in the treatment of glaucoma.
The advanced swept-source OCT technology allows visualization of the variations in the normal changes and those associated with aging in the posterior vitreous.
Every football fan knows the scrutiny that NFL game officials are put under every game day, and now a group of ophthalmologists is trying to ensure they can perform at their best each weekend.
Physicians note the impact of prism lenses can be life-changing for patients.
The treatment option can have a positive impact on quality of life for patients.
In this final episode, DMEI’s residents share their future plans for expanding the device capabilities and offer practical advice to other up-and-coming creators in eye care technology.
Older generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.
The unique MOA may deliver a synergistic effect when prescribed post-surgically.
Ophthalmologists can use OCT to find the early signs of disease
FDA approval of teprotumumab as therapeutic offers hope for patients.
Maximizing refractive surgery is key to ensuring prosperous future
John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.
Ehsan Sadri, MD, FACS, of Visionary Eye Institute in Newport Beach, California, sat down with Professor Emeritus Colin R. Green, PhD, DSc, University of Auckland, in Auckland, New Zealand, to learn more about a novel therapy in development for the treatment of keratoconus and other corneal ectasias.
AI’s use in diagnostic tools, surgical guidance, and its ethical considerations in ophthalmology are transforming the field
From easing fears to improving mood, a recent study explores how music transforms the surgical experience for both patients and health care teams.
Neurotech partners with Cencora for the U.S. launch of ENCELTO, the first FDA-approved treatment for MacTel, enhancing patient access and support.
At the Envision Summit 2025 in San Juan, Puerto Rico, Brittany Simmons, MD, discussed periorbital injuries and how they can affect the soft tissue and bones around the eye and gives insight into how clinicians should best go about treating it.
Abby Markward, MBA, executive director of the ASCRS Foundation and ASOA, discusses the foundation's global initiatives and the ASCRS Party for a Purpose.
At the Envision Summit 2025 in San Juan, Puerto Rico, retina program chairs Geeta Lalwani, MD, and Majda Hadziahmetovic, MD, discussed Hadziahmetovic's presentation on deep learning models of neovascular AMD as well as their time at the conference.
Answers to common questions that can help kick-start the journey into the metaverse to learn from the many virtual educational meetings and conference opportunities while mingling with colleagues worldwide.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Minimizing clinic visits, maximizing use of imaging modalities are key.
Ophthalmologists end their discussion on the management of dry eye disease with other ocular comorbidities highlighting key takeaways and prospective advances in care and outcomes.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Systemic immunosuppression may prevent devastating complication in patients.
Ophthalmologists can reduce IOP and medications with endocyclophotocoagulation while in the eye.
Procedure can improve best-corrected visual acuity, enhancing quality of life for patients.